Traumatic Brain Injury and Risk of Long-Term Brain Changes, Accumulation of Pathological Markers, and Developing Dementia: A Review
The DOI matches its Crossref record; 105 of the 106 references it cites were found in a registry or an index.
Abstract
Traumatic brain injuries (TBI) have received widespread media attention in recent years as being a risk factor for the development of dementia and chronic traumatic encephalopathy (CTE). This has sparked fears about the potential long-term effects of TBI of any severity on cognitive aging, leading to a public health concern. This article reviews the evidence surrounding TBI as a risk factor for the later development of changes in brain structure and function, and an increased risk of neurodegenerative disorders. A number of studies have shown evidence of long-term brain changes and accumulation of pathological biomarkers (e.g., amyloid and tau proteins) related to a history of moderate-to-severe TBI, and research has also demonstrated that individuals with moderate-to-severe injuries have an increased risk of dementia. While milder injuries have been found to be associated with an increased risk for dementia in some recent studies, reports on long-term brain changes have been mixed and often are complicated by factors related to injury exposure (i.e., number of injuries) and severity/complications, psychiatric conditions, and opioid use disorder. CTE, although often described as a neurodegenerative disorder, remains a neuropathological condition that is poorly understood. Future research is needed to clarify the significance of CTE pathology and determine whether that can explain any clinical symptoms. Overall, it is clear that most individuals who sustain a TBI (particularly milder injuries) do not experience worse outcomes with aging, as the incidence for dementia is found to be less than 7% across the literature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TBI is associated with an increased risk of dementia.[178][179][180]”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [179]
In the citing paper
“TBI is associated with an increased risk of dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [193]
In the citing paper
“The risk of dementia increases with the number of TBIs sustained.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [193]
Citations
Cites
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476 · cited 1×
“…and either resting tremor or rigidity) prior to onset of cognitive impairment, while DLB consists of two or more of the following symptoms: impaired and fluctuating cognition, recurrent visual hallucinations, REM sleep behavior disorder, and spontaneous motor changes similar to PD [70, 71].”
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
The spectrum of disease in chronic traumatic encephalopathy
McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., Lee, H.-S., Hall, G., Wojtowicz, S. M., Baugh, C. M., et al. (2013) · Brain · doi:10.1093/brain/aws307 · Cited by 2,098 · cited 1×
“Along these lines, a few studies have staged CTE pathology based on the amount and location of the characteristic tau patterns present [89], and have reported a gradual change in functioning for some cases with CTE pathology at all levels of pathological burden [79].”
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
Axonal pathology in traumatic brain injury
Johnson, V. E., Stewart, W., & Smith, D. H. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.013 · Cited by 1,273 · cited 1×
“Diffuse axonal injury can be induced during a TBI through several mechanisms, including axonal stretching or shearing, swelling, or secondary physiological changes downstream from neuronal damage (e.g., Wallerian degeneration) [3].”
Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football
Mez, J., Daneshvar, D. H., Kiernan, P. T., Abdolmohammadi, B., Alvarez, V. E., Huber, B. R., Alosco, M. L., Solomon, T. M., Nowinski, C. J., McHale, L., et al. (2017) · JAMA · doi:10.1001/jama.2017.8334 · Cited by 1,098 · cited 2×
“Non-specific factors such as impulsivity, irritability, depression, suicidality, substance misuse, gait instability, motor slowness, and attention and memory changes have been used to characterize cases with CTE pathology based on postmortem interviews with informants [79].”
Research works printed but not linked: 1
- Centers for Disease Control and Prevention, 2015, Atlanta, GA National Center for Injury Prevention and Control, Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation, 1
Cited by
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2025 Alzheimer's disease facts and figures
(2025) · Alzheimer's & Dementia · doi:10.1002/alz.70235 · Cited by 474
Hook, V., Yoon, M., Mosier, C., Ito, G., Podvin, S., Head, B. P., Rissman, R., O'Donoghue, A. J., & Hook, G. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140428 · Cited by 173
Hakiminia, B., Alikiaii, B., Khorvash, F., & Mousavi, S. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12767 · Cited by 110
“TBI is not only accompanied with short-term effects but also considered as a risk factor for long-term complications, including dementia and chronic traumatic encephalopathy [9, 10].”
BackgroundProtective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Bhalla, S., Mehan, S., Khan, A., & Rehman, M. U. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104896 · Cited by 108
2026 Alzheimer's disease facts and figures
(2026) · Alzheimer s & Dementia · doi:10.1002/alz.71345 · Cited by 108
Weiner, M. W., Harvey, D. J., Landau, S. M., Veitch, D. P., Neylan, T. C., Grafman, J. H., Aisen, P. S. S., Petersen, R. C., Jack, C. R., Tosun, D., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12712 · Cited by 54
“38 Indeed, co-pathologies such as α -synuclein and TAR DNA-binding protein 43 are commonly found to accompany A β and tau at autopsy in patients withclinicallydiagnosedprobableADandMCI.”
Hering, C., & Shetty, A. K. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad004 · Cited by 50
TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury
Gao, F., Hu, M., Zhang, J., Hashem, J., & Chen, C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02449-w · Cited by 50
“Overproduction of TDP-43 is a characteristic neurobiological feature in TBI-induced neuropathology [5, 35, 47, 72].”
BackgroundThe Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury
Villapol, S., Janatpour, Z. C., Affram, K. O., & Symes, A. J. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01435-8 · Cited by 49
“These intricate interlinked changes result in processes that lead to neurodegeneration and increase the risk for the later development of neurodegenerative disease [5, 6].”
BackgroundNeuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
Lerouet, D., Marchand‐Leroux, C., & Besson, V. C. (2021) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12656 · Cited by 49
Zhou, Y.-X., Chen, Q., Wang, Y.-L., Wu, H.-J., Xu, W.-L., Pan, Y., Gao, S., Dong, X., Zhang, J. H., & Shao, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00581 · Cited by 34
“Continued presence of some serum/plasma and CSF biomarkers is also able to persist many years post TBI, which depends on the type and extent of injury, thereby holding great promise for assessing the duration and degree of pathological processes (Williams et al., 2018; LoBue et al., 2019).”
BackgroundResultInfluentialLin, C.-T., Lecca, D., Yang, L.-Y., Luo, W., Scerba, M. T., Tweedie, D., Huang, P.-S., Jung, Y. J., Kim, D. S., Yang, C., et al. (2020) · eLife · doi:10.7554/elife.54726 · Cited by 41
Rabinowitz, A. R., Kumar, R. G., Sima, A. P., Venkatesan, U. M., Juengst, S. B., O’Neil-Pirozzi, T. M., Watanabe, T. K., Goldin, Y., Hammond, F. M., & Dreer, L. E. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2021.0038 · Cited by 39
“18 19–22 Alternatively, theoretical and empirical studies have proposed that TBI may accelerate the aging process, 23–27 resulting in health declines earlier than would be expected with typical aging.”
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Jung, Y. J., Tweedie, D., Scerba, M. T., Kim, D. S., Palmas, M. F., Pisanu, A., Carta, A. R., & Greig, N. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656921 · Cited by 38
Reiss, A. B., Montufar, N., DeLeon, J. R., Pinkhasov, A., Gomolin, I. H., Glass, A. D., Arain, H. A., & Stecker, M. M. (2021) · The Neurologist · doi:10.1097/nrl.0000000000000320 · Cited by 28
Association Between Gout and Dementia in the Elderly: A Nationwide Population-Based Cohort Study
Min, K. H., Kang, S. O., Oh, S. J., Han, J. M., & Lee, K. E. (2021) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.01.016 · Cited by 27
Attilio, P. J., Snapper, D. M., Rusnak, M., Isaac, A. J., Soltis, A. R., Wilkerson, M. D., Dalgard, C. L., & Symes, A. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.636259 · Cited by 27
“Angiotensin II has been shown to promote DNA replication in vascular smooth muscle and other cell types (Makita et al., 1995; Pawlikowski et al., 1999; Touyz et al., 1999; Chiu et al., 2003) and candesartan can mitigate angiotensin II induced DNA damage (Schmid et al., 2008).”
BackgroundNeuroethics across the Disorders of Consciousness Care Continuum
Young, M. J., & Peterson, A. H. (2022) · Seminars in Neurology · doi:10.1055/a-1883-0701 · Cited by 27
Clark, I., & Vissel, B. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201186 · Cited by 27
“from two independent sources [12, 13], that chronic”
Yang, Z., Tang, T., Li, P., Li, X., Wu, Y., Feng, D., Hu, M., Dai, F., Zheng, F., Zhang, W., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154168 · Cited by 26
Pham, T., Green, R., Neaves, S., Hynan, L. S., Bell, K. R., Juengst, S. B., Zhang, R., Driver, S. J., & Ding, K. (2022) · PM&R · doi:10.1002/pmrj.12854 · Cited by 26
Sharma, A., Muresanu, D. F., Nozari, A., Lafuente, J. V., Sahib, S., Tian, Z. R., Buzoianu, A. D., Patnaik, R., Wiklund, L., & Sharma, H. S. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.09.010 · Cited by 24
Neuropsychiatric Aspects of Impulse Control Disorders
Silva, B., Canas‐Simião, H., & Cavanna, A. E. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.001 · Cited by 22
Quantitative Imaging of Blood-Brain Barrier Permeability Following Repetitive Mild Head Impacts
Leaston, J., Qiao, J., Harding, I. C., Kulkarni, P., Gharagouzloo, C. A., Ebong, E. E., & Ferris, C. F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.729464 · Cited by 22
Cai, X., Harding, I. C., Sadaka, A. H., Colarusso, B. A., Kulkarni, P., Ebong, E. E., Qiao, J., O'Hare, N. R., & Ferris, C. F. (2021) · Brain Communications · doi:10.1093/braincomms/fcab265 · Cited by 22
Dong, H., Guo, L., Yang, H., Zhu, W., Liu, F., Xie, Y., Zhang, Y., Xue, K., Li, Q., Liang, M., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1129051 · Cited by 21
“Recently, researchers found that multiple modifiable risk factors like hypoperfusion, cardiovascular disease, physical activity, diet, education, social and cognitive engagement, and traumatic brain injury increased the development and progression of AD (Sando et al., 2008; Ronnemaa et al., 2011; Rusanen et al., 2011;…”
BackgroundHuang, P.-S., Tsai, P.-Y., Yang, L., Lecca, D., Luo, W., Kim, D. S., Hoffer, B. J., Chiang, Y. H., Greig, N. H., & Wang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158276 · Cited by 21
“It is one of the most important risk factors for the subsequent development of neurodegenerative disorders, particularly Parkinson’s disease and Alzheimer’s dementia [2,5], and is associated with changes in gene expressions in pathways that lead to these disorders [6,7].”
BackgroundZhou, J., Geng, Y., Su, T., Wang, Q., Ren, Y., Zhao, J., Fu, C., Weber, M., Lin, H., Kaminker, J. S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110557 · Cited by 21
Gibbons, L. E., Power, M. C., Walker, R. L., Kumar, R. G., Murphy, A., Latimer, C. S., Nolan, A., Melief, E. J., Beller, A., Bogdani, M., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221224 · Cited by 21
“Mostoftherecent studiesinvestigatingADriskfollowingTBIhave useddatafromtheNationalAlzheimer’sCoordinat-ing Center (NACC) database; these findings suggest earlier onset of AD among those with TBI [6–8] though rate of disease progression after diagnosis may not differ from uninjured controls [9, 10].”
Wang, Z., Li, J., Wang, A., Wang, Z., Wang, J., Yuan, J., Wei, X., Xing, F., Zhang, W., & Xing, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.658720 · Cited by 20
“The last few years have witnessed the recognition of traumatic brain injury (TBI) as a risk factor for development of chronic traumatic encephalopathy, dementia and various neurodegenerative disorders, accompanied by brain structural and functional alternations (LoBue et al., 2019).”
BackgroundTalbert, L. D., Kaelberer, Z., Gleave, E., Driggs, A., Driggs, A. S., Baldwin, S. A., Steffen, P. R., & Larson, M. J. (2024) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-024-09663-0 · Cited by 19
“Moderate-to-severe TBI is frequently associated with long-term declines in quality of life and increased risk for persistent neurological difficulties, such as dementia, memory decline, impaired judgment, and poor impulse control (Arulsamy et al., 2019; LoBue et al., 2019).”
Lecca, D., Hsueh, S., Luo, W., Tweedie, D., Kim, D. S., Baig, A. M., Vargesson, N., Kim, Y. K., Hwang, I., Kim, S., et al. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00907-5 · Cited by 17
Ding, K., Tarumi, T., Tomoto, T., Bell, K. R., Madden, C. J., Dieppa, M., Cullum, C. M., Zhang, S., & Zhang, R. (2021) · Brain Injury · doi:10.1080/02699052.2020.1865569 · Cited by 16
Self-citationGupta, A. K., Dovek, L., Proddutur, A., Elgammal, F. S., & Santhakumar, V. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.800733 · Cited by 15
Belding, J. N., Bonkowski, J. F., Englert, R. M., Stanfill, A. G., & Tsao, J. W. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1442715 · Cited by 14
Mollayeva, T., Sutton, M., Escobar, M. D., Hurst, M., & Colantonio, A. (2020) · PM&R · doi:10.1002/pmrj.12456 · Cited by 10
A population‐based study of head injury, cognitive function and pathological markers
James, S., Nicholas, J. M., Lane, C., Parker, T. D., Lu, K., Keshavan, A., Buchanan, S. M., Keuss, S. E., Murray‐Smith, H., Wong, A., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51331 · Cited by 10
“mild HI that is likely expected here, and could explain how HI-related changes affect whole brain volume and NAWM microstructural indexes.(2) Given the existing wider evidence, it is feasible that acute HI-induced brain volume loss and different microstructure occurs as a direct effect of the initial pathological resp…”
BackgroundFrom particulates to pathways: environmental exposures and their impact on Alzheimer’s disease
Liu, B., Ahmad, M. A., Abbas, G., Ahmed, U., Javed, R., Ali, I., Ao, Q., & Deng, X. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149880 · Cited by 8
Maigler, K. C., Buhr, T. J., Park, C. S., Miller, S. A., Kozlowski, D. A., & Marr, R. A. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.6989 · Cited by 8
Grasset, L., Power, M. C., Crivello, F., Tzourio, C., Chêne, G., & Dufouil, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220658 · Cited by 7
“This hypothesis is supported by studies reporting associations between TBI and markers of neuronal loss and brain atrophy such as hippocampal volume or brain volume loss, suggesting that TBI may promote neurodegeneration [27–29].”
Cognitive impairment following traumatic brain injury in Uganda: Prevalence and associated factors
Kintu, T. M., Katengeke, V., Kamoga, R., Nguyen, T., Najjuma, J., Kitya, D., Wakida, E. K., Obua, C., & Rukundo, G. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001459 · Cited by 5
“These include long-term brain changes and accumulation of pathological biomarkers in people with a history of TBI [12].”
BackgroundBigio, M. R. D., Krawitz, S., & Sinha, N. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad079 · Cited by 6
Khoury, M. A., Churchill, N. W., Battista, A. P. D., Graham, S. J., Symons, S. P., Troyer, A. K., Roberts, A., Kumar, S., Tan, B., Arnott, S. R., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12369-2 · Cited by 6
“…consistent with the behavioural evidence surrounding diffuse frontal injuries [56–63] and highlight an important need to track the progression of cognitive decline post-injury within these areas [53–59], with some cognitive tasks proving more sensitive to the detrimental effects of TBI than others.”
Jin, D., & Zhang, L. (2025) · Legal Medicine · doi:10.1016/j.legalmed.2025.102677 · Cited by 6
Hakiki, B., Pancani, S., Romoli, A. M., Draghi, F., Maccanti, D., Mannini, A., & Cecchi, F. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1106989 · Cited by 6
Schaffert, J., LoBue, C., Chiang, H., Peters, M. E., Hart, J., & Cullum, C. M. (2024) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acae003 · Cited by 6
Self-citationYang, Z., Li, X., Luo, W., Wu, Y., Tang, T., & Wang, Y. (2022) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2022.794342 · Cited by 6
Ma, X., Wang, H., Ye, G., Zheng, X., & Wang, Y. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.03.010 · Cited by 5
LoBue, C., Initiative, A. D. N., Kelley, B. J., Hart, J., Helphrey, J. H., Schaffert, J., Cullum, C. M., Peters, M. E., & Douglas, P. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220112 · Cited by 5
“Alzheimer’s disease (AD), though whether mild traumatic brain injury (mTBI) can be a risk factor is unclear and remains an important area for investigation [1].”
InfluentialSelf-citationSharma, H. S., Muresanu, D. F., Nozari, A., Lafuente, J. V., Buzoianu, A. D., Tian, Z. R., Huang, H., Feng, L., Bryukhovetskiy, I., Manzhulo, I., et al. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-32997-5_4 · Cited by 5
Bulut, E. A., Karabay, N., Soysal, P., & Işık, A. T. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1552690 · Cited by 5
Theadom, A., Barker-Collo, S. L., Parag, V., Caspi, A., Moffitt, T. E., Hogan, S., Ramrakha, S., & Poulton, R. (2023) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000875 · Cited by 4
Chu, S.-F., Liao, K.-H., & Li, W. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s452086 · Cited by 4
LoBue, C., Schaffert, J., Dams-O’Connor, K., Taiwo, Z., Sander, A. M., Venkatesan, U. M., O’Neil-Pirozzi, T. M., Hammond, F. M., Wilmoth, K., Ding, K., et al. (2023) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2023.04.017 · Cited by 4
Self-citationLoBue, C., Stopschinski, B. E., Saez-Calveras, N., Douglas, P. M., Huebinger, R. M., Cullum, C. M., Hart, J., & Gonzales, M. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-231027 · Cited by 4
Self-citationNozari, A., Sharma, A., Wang, Z., Feng, L., Muresanu, D. F., Tian, Z. R., Lafuente, J. V., Buzoianu, A. D., Wiklund, L., & SHARMA, H. S. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-32997-5_7 · Cited by 3
Kandikattu, S., Aavula, M., Parvizi, D., & Agrawal, D. K. (2026) · Archives of Clinical and Medical Case Reports · doi:10.26502/acmcr.96550754 · Cited by 2
“These various symptoms contribute to prolonged healthcare utilization, repeated hospitalizations, and long-term reliance on rehabilitation and support services [4].”
Traumatic Brain Injury and Risk of Incident Dementia: Forensic Applications of Current Research
Clem, M. A., LoBue, C., Schaffert, J., & Cullum, C. M. (2024) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acae076 · Cited by 2
Self-citationClark, I. A. (2021) · International Journal for Parasitology · doi:10.1016/j.ijpara.2021.10.002 · Cited by 2
Aβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2
Chu, S.-F., Ni, C., Liao, K.-H., & Wen, Y.-T. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241312985 · Cited by 2
“In 31 – 33 Secondary damage due to TBI may cause noticeable mechanisms of neuroin fl ammation and cytokine destruction.”
Risk Factors for Alzheimer Disease Development After Traumatic Brain Injury: A Preliminary Study
de Guise, É., Soucy, B., Joubert, S., Correa, J. A., & Dagher, J. H. (2021) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000481 · Cited by 2
Integrating Artificial Intelligence with Biomarkers to Meet the Challenges of Dementia
Ginn, C., Walker, R., Cruickshank, G. S., & Patel, B. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2040039 · Cited by 1
“TBI can lead to long-term brain changes, accumulation of pathological markers like A β and tau proteins, and cognitive impairment [73,74].”
Tomoto, T., Ding, K., Cullum, C. M., & Zhang, R. (2026) · Experimental Physiology · doi:10.1113/ep093330 · Cited by 1
Self-citationKluckert, C., & Hüll, M. (2024) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2230-1845 · Cited by 1
Incorporating advance care planning in dementia care
Giotas, D., & Dening, K. H. (2024) · Nursing Older People · doi:10.7748/nop.2024.e1463 · Cited by 1
Bulut, E. A., Soysal, P., & Işık, A. T. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1738434 · Cited by 1
White, L. R. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230332 · Cited by 1
“Several analyses addressing this important question have now been carried out by eminent researchers and reviewers employing impeccable data [1–4].”
Castro‐Gomez, S., Vieira-Saecker, A. M. M., Muñoz-Manco, J. I., Li, T., Kulińska, I., Weiss, F. D., Meissner, F., Schwartz, S., Stein, V., Latz, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.25.660862 · Cited by 1
‘Less common’ dementias affect many people
Dening, T., Karim, Z., & Davis, L. (2021) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2021.17.2.53
Brain trauma and neurodegenerative diseases
Růžička, F. (2021) · Neurologie pro praxi · doi:10.36290/neu.2021.104
Ahmed, F., Bukhari, I., Shah, S. A., Mehmood, S., Banaras, N., & Jahan, S. M. S. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22168945
Kluckert, C., & Hüll, M. (2023) · PSYCH up2date · doi:10.1055/a-1857-4819
“Auf pathophysiologischer Ebene konnten insbesondere für mittlere und schwere SHT strukturelle Hirnveränderungen und die Akkumulation pa-thologischer Demenzmarker, wie Amyloid und Tau, nach-gewiesen werden [24].”
Clinical significance of immunological indicators in the remote period after traumatic brain injury
Ovcharenko, M., Verbitsky, Y., Чумакова, И. Ю., & Yevtushenko, Y. O. (2024) · Ukrains kyi Visnyk Psykhonevrolohii · doi:10.36927/2079-0325-v32-is1-2024-3
Traumatic Brain Injury in Geriatric Patients
Borja, M. J., Guarnizo, A. P., Saigal, G. M., & Caban, K. M. (2025) · Springer eBooks · doi:10.1007/978-3-030-44092-3_52-1
LoBue, C., Stopschinski, B. E., Saez-Calveras, N., Salter, A. R., Galasko, D. R., Giza, C. C., Cullum, C. M., Douglas, P. M., & Hart, J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251325757
“31,32 Moreover, there have been limited studies on whether prior mTBI might predispose persons to have higher pathophysiological markers related to neurodegenerative disorders later-in-life.”
Self-citationTraumatic Brain Injury in Geriatric Patients
Borja, M. J., Guarnizo, A. P., Saigal, G. M., & Caban, K. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-78916-8_52
Chronic Traumatic Encephalopathy and Traumatic Brain Injury
Asken, B. M., Perry, D. C., & Gardner, R. C. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.019
Lopez-Caperuchipi, S. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-30268
Chiu, L. K. (2024) · eScholarship@McGill (McGill) · doi:10.82308/29066
Vire, J. (2024) · UTUPub (University of Turku)
Οι ανάγκες των φροντιστών σε ασθενείς με Κρανιοεγκεφαλική Κάκωση (ΚΕΚ)
Σταυρίδου, Σ. Π. (2023) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.38762
Yu, Y. H., Lee, Y. R., Park, D., Song, B., & Kim, D.-S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020597
“TBI is classified as mild, moderate, or severe according to clinical parameters, including level of consciousness, presence and duration of amnesia, and other neurological manifestations [2].”
Traumatic Brain Injury: Sex and Gender Considerations Relevant to Rehabilitation
Hanafy, S. (2023) · TSpace (University of Toronto)
Khoury, M. A. (2024) · TSpace (University of Toronto)
Kluckert, C., & Hüll, M. (2026) · Neurologie up2date · doi:10.1055/a-2770-4235
Predicting recovery of patients after traumatic brain injury
Агарков, Н. М., & Lysenko, A. S. (2026) · Proceedings of the Southwest State University Series IT Management Computer Science Computer Engineering Medical Equipment Engineering · doi:10.21869/2223-1536-2026-16-1-38-49
Hung, K.-C., Weng, H.-L., Lai, Y.-C., & Chen, I. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1870929
Accelerated brain aging with functional and cognitive decline after traumatic brain injury
Samuel, I. B. H., Pollin, K. U., Chun, T. J., Forsten, R. D., Barrett, J., Reinhard, M. J., & Costanzo, M. E. (2026) · Trauma · doi:10.1177/14604086261494740
Dementia assessments in older adults: behavioural and clinical markers of risk
de Backker, P. (2026) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.86293
Leaston, J., Qiao, J., Harding, I. C., Kulkarni, P., Gharagouzloo, C., Ebong, E., & Ferris, C. F. (2021) · doi:10.3389/fneur.2021.729464.s003
Hakiki, B., Pancani, S., Romoli, A. M., Draghi, F., Maccanti, D., Mannini, A., & Cecchi, F. (2023) · doi:10.3389/fneur.2023.1106989.s001
Metadata
- Authors
- LoBue, C., Munro, C., Schaffert, J., Didehbani, N., Hart, Batjer, H., & Cullum, C. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
- The University of Texas at Dallas (US)
- Corresponding author
- LoBue, Christian
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2019-08-03
- Volume
- 70
- Issue
- 3
- Pages
- 629-654
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2954482986
- Cited by
- 86
- References
- 106
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 11 · 2023: 17 · 2022: 13 · 2021: 18 · 2020: 9
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (F31AG059372)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- traumatic brain injury, chronic traumatic encephalopathy
- MeSH terms
- Neuropathology, Brain Injuries, Traumatic, Brain, Dementia, Humans, Risk Factors, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.